Bonifacio, E.* ; Mathieu, C.* ; Nepom, G.T.* ; Ziegler, A.-G. ; Anhalt, H.* ; Haller, M.J.* ; Harrison, L.C.* ; Hebrok, M.* ; Kushner, J.A.* ; Norris, J.M.* ; Peakman, M.* ; Powers, A.C.* ; Todd, J.A.* ; Atkinson, M.A.*
Rebranding asymptomatic type 1 diabetes: The case for autoimmune beta cell disorder as a pathological and diagnostic entity.
Diabetologia 60, 35-38 (2017)
The asymptomatic phase of type 1 diabetes is recognised by the presence of beta cell autoantibodies in the absence of hyperglycaemia. We propose that an accurate description of this stage is provided by the name 'Autoimmune Beta Cell Disorder' (ABCD). Specifically, we suggest that this nomenclature and diagnosis will, in a proactive manner, shift the paradigm towards type 1 diabetes being first and foremost an immune-mediated disease and only later a metabolic disease, presaging more active therapeutic intervention in the asymptomatic stage of disease, before end-stage beta cell failure. Furthermore, we argue that accepting ABCD as a diagnosis will be critical in order to accelerate pharmaceutical, academic and public activities leading to clinical trials that could reverse beta cell autoimmunity and halt progression to symptomatic insulin-requiring type 1 diabetes. We recognize that there are both opportunities and challenges in the implementation of the ABCD concept but hope that the notion of 'asymptomatic autoimmune disease' as a disorder will be widely discussed and eventually accepted.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Autoimmunity ; Beta Cell ; Diabetes ; Disease Classification; Risk
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2017
Prepublished im Jahr
2016
HGF-Berichtsjahr
2016
ISSN (print) / ISBN
0012-186X
e-ISSN
1432-0428
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 60,
Heft: 1,
Seiten: 35-38
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Springer
Verlagsort
Berlin ; Heidelberg [u.a.]
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30201 - Metabolic Health
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502100-001
Förderungen
Copyright
Erfassungsdatum
2016-12-31